Lacktman, Ferrante Comment on Effort to Loosen Telemedicine Restrictions for Prescribing

14 January 2019 mHealthIntelligence News
Partner Nate Lacktman and Senior Counsel TJ Ferrante were quoted in an mHealthIntelligence article, “ATA Presses DEA to Loosen Telemedicine Restrictions for Prescribing,” about a letter from the American Telemedicine Association urging federal authorities to loosen the reins on regulations that restrict mental health professionals from prescribing controlled substances via telehealth.

A blog post by the pair, who worked with the ATA on its recommendations, said the SUPPORT for Patients and Communities Act, which is designed to tackle the nation’s ongoing opioid abuse epidemic, was changed prior to passage to specifically require the U.S. Drug Enforcement Administration to gather public comments – thus enabling the ATA and others to make their opinions heard.

“The recommendations are designed to strike a balance between the country’s great need for additional behavioral health resources, commonly accepted clinical practices, the evolving landscape of telemedicine technologies, and DEA’s charge to protect the safety and wellbeing of citizens via drug diversion,” he wrote.

Related Services

Insights

CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
Data Processing Patent Eligibility: Federal Circuit Finds Claims Eligible in KPN v. Gemalto
19 November 2019
IP Litigation Current
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA